Smilax glabra
Smilax glabra · Accepted scientific name
Scientific literature: Very Sparse (2 studies) · ★☆☆☆☆
Smilax glabra is a versatile medicinal plant primarily utilized for its bioactive properties found within its rhizome. Scientific research highlights its significant antioxidant and antiviral activities, which are driven by key chemical constituents such as astilbin, flavonoids, and engeletin. Various preparations, including fresh samples, crude ethanol extracts, and TFSG, are studied to harness these therapeutic benefits. These extracts show great promise in addressing diverse health conditions, ranging from arthritis and bone regeneration to the treatment of infectious diseases. Furthermore, its pharmacological potential extends to combating specific parasitic threats like Clonorchis sinensis.
- Synonyms
- Smilax Blinii · Smilax Mengmaensis · 5 more
- Common names
- Not available
- Family
- Smilacaceae
- Distribution
- Asia-Tropical
- Plant Parts
- Rhizome
Classification
Common Names
Smilax glabra is a versatile plant known by many different names across various cultures and languages. In English-speaking regions, it is frequently referred to as Chinese smilax or glabrous greenbrier. It is also widely recognized by the common name chinaroot, highlighting its botanical identity. International recognition continues with names like Смилакс голый in Russian and ข้าวเย็นใต้ in Thai. These diverse designations illustrate the global presence and multifaceted identity of this specific species.
Sources: Catalogue of Life (COL)
Synonyms
Smilax glabra is a botanical subject that has been identified by several different scientific names throughout history. Researchers have frequently documented this species under various synonyms, including Smilax blinii and Smilax hookeri. It is also closely associated with Smilax dunniana and the specific variety known as Smilax calophylla var. concolor. Furthermore, the plant is sometimes categorized as Smilax glabra var. maculata in different taxonomic contexts. Understanding these overlapping relationships is essential for ensuring accuracy in botanical classification and study.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Smilax glabra is a remarkable organism that belongs to the kingdom Plantae. Within this vast kingdom, the species is classified under the class Equisetopsida. It further falls into the order Liliales, showcasing its unique evolutionary position. As a member of the genus Smilax, it represents a specialized lineage of climbing plants. Ultimately, its biological identity is defined by its placement within the family Smilacaceae.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Liliales |
| Family | Smilacaceae |
| Genus | Smilax |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Smilax glabra is widely distributed across the temperate regions of Asia, with a particularly strong presence throughout China. Its range extends across diverse landscapes, encompassing the North-Central and South-Central territories of the country. The plant is also commonly found in the Southeast regions and the tropical island of Hainan. Additionally, its adaptability allows it to thrive within the unique high-altitude environments of Tibet. This broad geographic spread highlights the species' resilience across various Chinese ecosystems.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Smilax glabra is a shrubby plant characterized by its robust and distinct growth form. As a self-supporting species, it maintains its upright structure without the need for external assistance.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Smilax glabra is a medicinal plant that possesses significant biological properties, including both antioxidant and antiviral activities. Research into its total flavonoids has demonstrated that these compounds can be encapsulated in nanoparticles to enhance their antioxidant capacity and protect cells from oxidative damage. Additionally, specific glycoproteins isolated from the plant's rhizome have shown a notable ability to combat viral infections. These antiviral proteins have specifically demonstrated effectiveness against respiratory syncytial virus and Herpes simplex virus type 1. Together, these findings highlight the diverse therapeutic potential inherent in the chemical constituents of Smilax glabra.
Compounds
Smilax glabra is a medicinal plant that serves as a rich source of diverse bioactive compounds, most notably a variety of flavonoids. Within these flavonoid profiles, specific constituents such as astilbin and engelitin have been identified as key index components during purification processes. Research also highlights the presence of glycoproteins in the rhizomes, which exhibit significant antiviral and anti-proliferative properties. The complex chemical makeup of the plant includes both specialized molecules like astilbin and various glycosides that contribute to its traditional medicinal uses. Ultimately, the synergy of these diverse phytochemicals, including flavonoids and glycoproteins, underscores the plant's therapeutic potential.
Conditions
Smilax glabra demonstrates significant therapeutic potential by helping to regulate inflammatory responses and promote bone regeneration to treat arthritis. The plant also exhibits effective wormicidal properties against the parasite Clonorchis sinensis. Furthermore, its flavonoids can be utilized to enhance protection against H2O2-induced oxidative damage to HepG2 cells. Research indicates that ethanolic extracts of the plant show inhibitory activity against HIV-1 integrase. Additionally, glycoproteins isolated from its rhizome possess potent antiviral activity against Herpes simplex virus type 1 (HSV-1).
Preparations
Smilax glabra is prepared as an EtOH extract to demonstrate inhibitory effects against HIV-1 integrase. The plant is also prepared as TFSG, which can be encapsulated into zein-lecithin complex nanoparticles to improve antioxidant stability. Furthermore, Smilax glabra is prepared as crude ethanol extracts that exhibit high hepatoprotective activities against oxidative stress in HepG2 cells. In some traditional applications, Smilax glabra is prepared as fresh material to utilize its potent anti-inflammatory effects through PDE4 inhibition. Finally, Smilax glabra is prepared as gold nanoparticles synthesized from its rhizome to modulate anti-obesity and anti-diabetic parameters in animal models.
Parts used
Smilax glabra utilizes its rhizome as a primary source of various bioactive chemical constituents. Research has successfully isolated several dihydroflavonol glycosides, such as astilbin and neoastilbin, from these underground structures. Beyond small molecules, the rhizome also contains specific glycoproteins that exhibit significant antiviral and anti-proliferative properties. These rhizome extracts have been widely utilized in Traditional Chinese and Thai medicine to address immunological disorders and infectious diseases. Ultimately, the therapeutic potential of the plant appears to stem from a complex synergy of phytochemicals found within the rhizome.